BioAmber logo — Embracing a sustainable future through innovative biochemica...

BioAmber

Embracing a sustainable future through innovative biochemicals

Founded 2008 Post Ipo Debt Total: $159.00M Biotechnology

General Information

Company Name BioAmber
Founded Year 2008
Industries Biotechnology
Funding Stage Post Ipo Debt
Social

Get notified when BioAmber moves

Funding, new markets, leadership changes, hiring surges — one e-mail, only when something happens.

Free · no account needed

About BioAmber

BioAmber is a biotechnology startup that envisions a sustainable future through innovative biochemicals. Established in 2008 as DNP Green Technology, the company underwent a name change to BioAmber after acquiring a joint venture with ARD. Post-acquisition, the company retained the BioAmber name from the joint venture. The latest investment of $10.00M in Post-IPO Debt came on 26 April 2016, with BDC Venture Capital being the investing entity. Headquartered in the United States and incorporated in Delaware, BioAmber is making strides in the biotechnology industry with its sustainable approach and innovative solutions.

Taxonomy: Sustainable future, Biochemicals, Innovation, BioAmber, Delaware, DNP Green Technology, Acquisition, Joint venture, ARD, Private company, US-based, Renewable resources, Bio-based chemicals, Green technology

Funding Rounds & Investors (8)

View All
Funding Stage Amount Investors Lead Investors Date
Post-IPO Debt •••••• 1 •••• •••• 26 Apr 2016
Grant •••••• 1
Investor
02 Jul 2014
Post-IPO Debt •••••• 2
Investor
•••• ••••
23 Jun 2014
Post-IPO Debt •••••• 1 •••• •••• 19 Feb 2014
Post-IPO Debt •••••• 1
Investor
18 Jul 2013

View All 8 Funding Rounds

BioAmber Alternatives & Competitors

BioAmber vs

A cloud-based platform for testing and monitoring the functionality of mobile apps and websites

Acquired
4 employees
Computing, Digital Media
BioAmber vs

Pioneering the future of renewable energy with advanced wind farms, hydropower projects, and innovat...

9 employees
Energy, Renewable Energy
BioAmber vs
71 CONSTRUCTION
71 CONSTRUCTION United States

We are the professional leader for all your construction needs.

36 employees
Prop Tech, Construction

FAQ About BioAmber

Embracing a sustainable future through innovative biochemicals
BioAmber was founded in 2008.
BioAmber operates in the following industries: Biotechnology.
BioAmber has completed 8 funding rounds, raising a total of $159.00M. The latest funding stage is Post Ipo Debt.
Top alternatives and competitors to BioAmber include Keynote DeviceAnywhere, Karma Energy Ltd, 71 CONSTRUCTION, 14Trees, Winova India. These companies operate in related industries and serve comparable markets. You can compare them side by side on Bounce Watch.
BioAmber and Keynote DeviceAnywhere are both companies in similar industries. Compare their funding, team size, growth signals, and market position on Bounce Watch to see which one fits your needs.

Don't just browse. Track.

Signal Tracker monitors BioAmber and millions of companies for funding rounds, hiring surges, product changes, and 40+ signal types — so you never miss an opportunity.

One analytics cookie (Google Analytics). Cookie Policy